Add Alzheimer's disease to the list of autoimmune diseases

被引:92
作者
D'Andrea, MR [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Spring House, PA 19477 USA
关键词
D O I
10.1016/j.mehy.2004.08.024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A sole pathological event leading to Alzheimer's disease (AD) remains undiscovered in spite of decades of costly research. In fact, it is more probable that the causes of AD are the result of a myriad of intertwining pathologies. However, hope remains that a single awry event could lead to the many pathological events observed in AD brain tissues thereby creating the presentation of simultaneous pathologies. Age-related vascular diseases, which include an impaired blood-brain barrier (BBB), are a common denominator associated with various degrees of dementia, including AD. Recently, a key finding not only demonstrated the anomalous presence of immunoglobulin (Ig) detection in the brain parenchyma of AD tissues but, most importantly, specific neurons that showed degenerative, apoptotic features contained these vascular-derived antibodies. In addition, subsequent studies detected classical complement components, C1q and C5b-9, in these Ig-positive neurons, which also were spatially more associated with reactive microglia over the Ig-negative neurons. Thus, it is possible that the mere presence of anti-neuronal autoantibodies in the serum, whose importance had been previously dismissed, may be without pathological consequence until there is a BBB dysfunction to allow the deleterious effects of these autoantibodies access on their targets. Hence, these observations suggest autoimmunity-induced cell death in AD. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 58 条
[41]   ANTI-CNS ANTIBODIES IN NEUROLOGICAL AND PSYCHIATRIC-DISORDERS [J].
PLIOPLYS, AV ;
THIBAULT, J ;
BOUCHARD, JP ;
COCKBURN, C ;
HAWKES, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (11) :1514-1521
[42]   ANTIBODIES REACTIVE WITH NEURONS IN SLE PATIENTS WITH NEUROPSYCHIATRIC MANIFESTATIONS [J].
QUISMORIO, FP ;
FRIOU, GJ .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1972, 43 (05) :740-748
[43]  
RAPOPORT SI, 1980, CEREBRAL METABOLISM, P96
[44]   A vascular connection to Alzheimer's disease [J].
Rhodin, J ;
Thomas, T .
MICROCIRCULATION, 2001, 8 (04) :207-220
[45]   COMPLEMENT ACTIVATION BY BETA-AMYLOID IN ALZHEIMER-DISEASE [J].
ROGERS, J ;
COOPER, NR ;
WEBSTER, S ;
SCHULTZ, J ;
MCGEER, PL ;
STYREN, SD ;
CIVIN, WH ;
BRACHOVA, L ;
BRADT, B ;
WARD, P ;
LIEBERBURG, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10016-10020
[46]   AUTOANTIBODIES TO GLUTAMATE-RECEPTOR GLUR3 IN RASMUSSENS ENCEPHALITIS [J].
ROGERS, SW ;
ANDREWS, PI ;
GAHRING, LC ;
WHISENAND, T ;
CAULEY, K ;
CRAIN, B ;
HUGHES, TE ;
HEINEMANN, SF ;
MCNAMARA, JO .
SCIENCE, 1994, 265 (5172) :648-651
[47]   BETA-AMYLOID-(1-42) IS A MAJOR COMPONENT OF CEREBROVASCULAR AMYLOID DEPOSITS - IMPLICATIONS FOR THE PATHOLOGY OF ALZHEIMER-DISEASE [J].
ROHER, AE ;
LOWENSON, JD ;
CLARKE, S ;
WOODS, AS ;
COTTER, RJ ;
GOWING, E ;
BALL, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10836-10840
[48]   Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging [J].
Starr, JM ;
Wardlaw, J ;
Ferguson, K ;
MacLullich, A ;
Deary, IJ ;
Marshall, I .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01) :70-76
[49]   Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination [J].
Storch, MK ;
Piddlesden, S ;
Haltia, M ;
Iivanainen, M ;
Morgan, P ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1998, 43 (04) :465-471
[50]  
Thomas T, 1997, J SUBMICR CYTOL PATH, V29, P293